Literature DB >> 12758065

Molecular investigation of TBP allele length: a SCA17 cellular model and population study.

Suzanne J Reid1, Mark I Rees, Willeke M C van Roon-Mom, A Lesley Jones, Marcy E MacDonald, Greg Sutherland, Matthew J During, Richard L M Faull, Michael J Owen, Mike Dragunow, Russell G Snell.   

Abstract

Recently, an inherited spinocerebellar ataxia (SCA17) has been attributed to polyglutamine coding expansions within the gene coding for human TATA-box binding protein (TBP). The normal repeat range is 25-42 units with patients having as few as 46 repeats. We undertook a TBP repeat length population study showing its relative stability, skewed distribution, and substantial population specific differences. To investigate the mechanism of neurodegeneration in SCA17 we have developed a cellular model expressing full-length TBP with a range of polyQ expansions. As has been found with other polyQ cellular models, insoluble intracellular inclusions form in a repeat-length-dependent manner. In addition, we have shown that the expanded TBP polyQ tract is able to interact with other overexpressed polyQ-containing proteins. Importantly, overexpression of expanded TBP results in increased Cre-dependent transcriptional activity. As TBP is required for transcription by all RNA polymerases, this may indicate a mechanism for aberrant polyQ gain of function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12758065     DOI: 10.1016/s0969-9961(03)00014-7

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  12 in total

Review 1.  Hold me tight: Role of the heat shock protein family of chaperones in cardiac disease.

Authors:  Monte S Willis; Cam Patterson
Journal:  Circulation       Date:  2010-10-26       Impact factor: 29.690

2.  Spinocerebellar ataxia type 17 in a patient from an Indian kindred.

Authors:  Dietrich Haubenberger; Daniela Prayer; Peter Bauer; Walter Pirker; Alexander Zimprich; Eduard Auff
Journal:  J Neurol       Date:  2006-09-13       Impact factor: 4.849

3.  Downregulation of proteins involved in the endoplasmic reticulum stress response and Nrf2-ARE signaling in lymphoblastoid cells of spinocerebellar ataxia type 17.

Authors:  Li-Ching Lee; Yu-Ting Weng; Yih-Ru Wu; Bing-Wen Soong; Yung-Che Tseng; Chiung-Mei Chen; Guey-Jen Lee-Chen
Journal:  J Neural Transm (Vienna)       Date:  2014-01-11       Impact factor: 3.575

4.  Mutation at the SCA17 locus is not a common cause of primary dystonia.

Authors:  Kathrin Grundmann; Ulrike Laubis-Herrmann; Dirk Dressler; Juliane Vollmer-Haase; Peter Bauer; Manfred Stuhrmann; Thorsten Schulte; Ludger Schöls; Helge Topka; Olaf Riess
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

5.  Molecular mechanisms underlying Spinocerebellar Ataxia 17 (SCA17) pathogenesis.

Authors:  Su Yang; Xiao-Jiang Li; Shihua Li
Journal:  Rare Dis       Date:  2016-08-12

Review 6.  The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review.

Authors:  R Walsh; E Storey; D Stefani; L Kelly; V Turnbull
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

7.  Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity.

Authors:  Meyer J Friedman; Chuan-En Wang; Xiao-Jiang Li; Shihua Li
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

8.  Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.

Authors:  Anjali G Shah; Meyer J Friedman; Shanshan Huang; Meredith Roberts; Xiao-Jiang Li; Shihua Li
Journal:  Hum Mol Genet       Date:  2009-07-30       Impact factor: 6.150

9.  Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4).

Authors:  Giovanni Stevanin; Alexis Brice
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

10.  Role of the CCAAT-binding protein NFY in SCA17 pathogenesis.

Authors:  Li-Ching Lee; Chiung-Mei Chen; Hao-Chun Wang; Hsiao-Han Hsieh; I-Sheng Chiu; Ming-Tsan Su; Hsiu-Mei Hsieh-Li; Chung-Hsin Wu; Guan-Chiun Lee; Guey-Jen Lee-Chen; Jung-Yaw Lin
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.